Table 2 Correlation between the clinicopathologic features and expression of CENP-H protein
From: Prognostic relevance of Centromere protein H expression in esophageal carcinoma
| Â | CENP-H | Â | |
|---|---|---|---|
Characteristics | Low expression | High expression | P |
Gender | Â | Â | Â |
   Male | 67(51.9) | 62(48.1) | 0.013 |
   Female | 31(73.8) | 11(26.2) |  |
Age(y) | Â | Â | Â |
   ≥ 60 | 58(56.3) | 45(43.7) | 0.747 |
   <60 | 40(58.8) | 28(41.2) |  |
Stage | Â | Â | Â |
   I | 9(90.0) | 1(10.0) |  |
   II a | 46(61.3) | 29(38.7) |  |
   II b | 9 (64.3) | 5(35.7) | 0.023* |
   III | 30(47.6) | 33(52.4) |  |
   IV | 4(44.4) | 5(55.6) |  |
Histological differentiation | Â | Â | Â |
   Well | 30(54.5) | 25(45.5) |  |
   Moderate | 42(58.3) | 30(41.7) | 0.637 |
   Poor | 26(59.1) | 18(40.9) |  |
Tumor diameter | Â | Â | Â |
   ≥ 40 mm | 37(51.4) | 35(48.6) | 0.184 |
   <40 mm | 61(61.6) | 38(38.4) |  |
Depth of invasion | Â | Â | Â |
   Submucosa | 8(66.7) | 4(33.3) | 0.212 |
   Muscularis propria | 36(60.7) | 22(39.3) |  |
   Adventitia | 54(53.8) | 47(46.2) |  |
pT classification | Â | Â | Â |
   T1~T2 | 41(69.5) | 18(30.5) | 0.019 |
   T3~T4 | 57(50.9) | 55(49.1) |  |
pN classification | Â | Â | Â |
   YES | 38(49.4) | 39(50.6) | 0.057 |
   NO | 60(63.8) | 34(36.2) |  |
pMetastasis | Â | Â | Â |
   YES | 4(44.4) | 5 (55.6) | 0.426 |
   NO | 94(58.0) | 68 (42.0) |  |